About Us Need Analysis Services What's New Key Clients Resources Contact Us
About Us

James McHale | David Gondak | Joycellen Auritt | Ralph Picard | William Gaskins | Alfred Hurd | Debra Franke
Lee Ginsburg | Marlys Hanson | Michael Doré | Richard Sands | John Snyder | Gary Bowman | Linda Keane | Karen Lawson

John E. Snyder, Senior Consultant

John Snyder is a quality professional with 25 years experience in industry with companies including Merck, Novartis and Johnson & Johnson. His senior management and consulting experience encompasses the biologic, biopharmaceutical, drug, medical device and medical gas industries. John has thousands of hours of hands-on experience working with FDA investigators and thought leaders across many districts. He has helped companies to navigate through FDA enforcement actions, including warning letters and consent decrees with effective corrective and preventive action planning and implementation. He has also prepared firms for routine FDA inspections, as well as pre-approval inspections for new products.

John's expertise includes quality system assessment, development and planning. He is an expert in helping clients to design quality systems that are both regulatory secure and effective business processes. His approach integrates the quality function and the quality system into the strategic planning process of the business to help sustain regulatory compliance.

John has lectured and conducted workshops in the area of crisis management based upon his experience with handling suspected product tampering of over the counter medications. He is an invited speaker for key professional organizations and has published on various quality and regulatory topics.

John has a B.A. in Biology and is a registered medical technologist. He holds an M.S. in Animal Pathology from the University of Rhode Island and an M.S. in Pharmaceutics from Temple University School of Pharmacy. He did special studies at Yale University in Diagnostic Virology. John is a member of the American Society for Quality, the Regulatory Affairs Professional Society, the Parenteral Drug Association and the American Management Association. He is also a member of the scientific honor society, Sigma Xi.

John is very effective in helping organizations to design effective quality systems and sustainable regulatory compliance in both crisis and preventive circumstances.


back to top